Company intelligence / Profile preview

Elevai Labs Inc.

Newport Beach, California, USAelevailabs.com ↗

Ownership: Public · ELAB
Development stage: Phase 1

Overview

Elevai Labs has commercialized a line of physician-dispensed stem cell-derived exosome skincare products aimed at post-procedure care and ongoing skin maintenance. The company recently expanded into biopharmaceutical R&D with preclinical programs focused on engineered probiotics to address muscle loss in patients undergoing weight loss treatments such as GLP‑1 receptor agonists. All current revenue comes from the commercial sale of its skincare line; drug development programs are not yet in clinical trials.

Therapeutic areas: DermatologyMetabolic Disorders
Modalities: Exosome-based therapeutics and skincare products (stem cell-derived exosomes)Engineered probiotics (for metabolic health/obesity)
Industry: Biotech

Drug pipeline

1 asset

Empower

Unknown

Partnerships

MOA Life Plus Co. Ltd. (exclusive agreement to develop new compounds outside South Korea)

Beyond the preview

Go deeper on Elevai Labs Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elevai Labs Inc..